Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Digital diabetes therapy

Dear Sir or Madam,

Diabetes is most likely one of the most common diseases of civilization – according to WHO, there are currently 425 million adults worldwide suffering from it. This makes diabetes not only a heavy burden for the health systems, but its various secondary diseases jeopardize the health of many affected people. In our Topic of the Month, we take a look at how the digital diabetes management of the future makes it easier for them to deal with their disease and to avoid secondary damage as well.

Have a great start into the new year,

Timo Roth
Editorial team MEDICA-tradefair.com

MEDICA Trade Fair with Conferences and Forums
Monday to Thursday
18-21 November 2019
Düsseldorf, Germany

Table of Contents

Topic of the Month: Modern Diabetes Therapies
Interview: Retina measurements with Mimo
Newsletter Service
RSS Service
Newsletter Archive

Collect, process, communicate – retina measurements with Mimo

Interview

Image: Woman puts her arms around the retina scanner and looks smilingly to the side into the camera; Copyright: Mimo AG
Continuous monitoring is an essential process with every disease. In the case of eye disorders, frequent retina measurements can facilitate early detection of deterioration to quickly initiate intervention. This calls for comprehensive care settings, easy ways to take measurements and prompt results. However, in reality, this is rarely the case.
Read the interview here:
Collect, process, communicate – retina measurements with Mimo
All interviews at MEDICA-tradefair.com
To top

Research & Technology

Sensors to detect and measure cancer's ability to spread

The spread of invasive cancer cells from a tumor's original site to distant parts of the body is known as metastasis. It is the leading cause of death in people with cancer. In a paper published online in iScience, University of California San Diego School of Medicine researchers reported engineering sensors that can detect and measure the metastatic potential of single cancer cells.
read more
To top

Research & Technology

Machine learning may predict a healthy old age

For a study published in Genome Biology, a team at the Salk Institute analyzed skin cells ranging from the very young to the very old and looked for molecular signatures that can be predictive of age. Developing a better understanding of the biological processes of aging could eventually help to address health conditions that are more common in old age, such as heart disease and dementia.
read more
To top

Research & Technology

Novel imaging technique brings diagnostic potential into operating room

A team of University of Illinois at Urbana-Champaign researchers led by Professor Stephen Boppart has successfully visualized the tumor microenvironment of human breast tissue shortly after it was surgically removed from a patient in the operating room. The researchers achieved this using a new portable optical imaging system developed in Boppart's lab.
read more
To top

Research & Technology

Higher radiation dose increases cancer risk

Extremely obese people are needing a far higher dose of radiation during x-ray examinations than people of normal weight, increasing their risk of cancer, new research has shown.
read more
To top

Blood glucose monitoring of tomorrow - modern diabetes therapies

Topic of the Month

Image: Diabetic woman with sensor; Copyright: panthermedia.net / Click and Photo
There are 425 million people with diabetes in the World.. Heart problems, kidney failure or blindness - these can all be consequences of the metabolic disease. In order to avoid damage to organs or body parts, it is important to recognize them early and treat them correctly. Medical technological progress is a top priority: Thanks to modern diagnostic and therapeutic methods, diabetes patients now have the possibility of being treated digitally.
Read more in our Topic of the Month:
Blood glucose monitoring of tomorrow - modern diabetes therapies
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Wolfram N. Diener, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Messe Düsseldorf GmbH processes your personal data. The data protection regulations of Messe Düsseldorf GmbH hold information in closer detail to this subject and are available under www.messe-duesseldorf.de/privacy. You may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, VG-R, PF 101006, 40001 Düsseldorf, Germany.

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.